Patent · US Expired

4(5)-substituted imidazole derivatives as .alpha..sub.2 -adrenergic receptor blockers

US4933359A · kind A · utility

1Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 14, 1987
Grant dateJun 12, 1990
Priority date
Expiry dateMay 14, 2007

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D233/64
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides 4(5)-substituted imidazole derivatives of formula ##STR1## and their acid addition salts, in which either X is --CH.sub.2 -- and R.sub.1 is --CN, --COOH, COO(lower alkyl), --CHO, --CO(lower alkyl), lower alkyl or 3 or 5 carbon atoms, lower alkenyl, or lower (hydroxy alkyl) or X is ##STR2## --C(:CH--R)-- or --CH(CH.sub.2 R)--, where R is hydrogen or lower alkyl, and R.sub.1 is lower alkyl, and R.sub.3 and R.sub.4 are each hydrogen, methyl, ethyl, methoxy, or halogen, and novel intermediates and processes for their preparation. These compounds, in particular when R.sub.1 is lower alkyl, lower alkenyl, or lower (hydroxy alkyl), possess valuable pharmacological properties and are useful especially as selective .alpha..sub.2 -receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.